Jan 26 (Reuters) -
* MODERNA STARTS CLINICAL TRIAL OF BOOSTER SHOT TARGETING OMICRON COVID VARIANT - CNBC Further company coverage:
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
133.4 USD | -0.74% |
|
-4.73% | +34.14% |
Jun. 20 | Argus Raises Moderna's Price Target to $150 From $115 | MT |
Jun. 14 | FDA asks COVID vaccine makers to target KP.2 strain with updated shots | RE |
Jan 26 (Reuters) -
* MODERNA STARTS CLINICAL TRIAL OF BOOSTER SHOT TARGETING OMICRON COVID VARIANT - CNBC Further company coverage:
1st Jan change | Capi. | |
---|---|---|
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+34.92% | 38.48B | |
+12.62% | 26.36B | |
-12.11% | 26.22B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B | |
-10.49% | 10.9B |